Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Branch Retinal Vein Occlusion”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Not applicableStudy completedNCT01219205
What this trial is testing

Major and Macular Branched Retinal Venous Occlusion

Who this might be right for
Macular Edema
Hallym University Medical Center 46
Large-scale testing (Phase 3)Ended earlyNCT00642226
What this trial is testing

Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Helse Stavanger HF 34
Large-scale testing (Phase 3)WithdrawnNCT00406380
What this trial is testing

Effect of Avastin in Juxtafoveal Telangiectasias

Who this might be right for
Telangiectasis
Asociación para Evitar la Ceguera en México
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Not applicableStudy completedNCT00612261
What this trial is testing

Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein Occlusion
Yonsei University 40
Large-scale testing (Phase 3)Study completedNCT01535261
What this trial is testing

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Novartis Pharmaceuticals 357
Not applicableWithdrawnNCT04011358
What this trial is testing

Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study

Who this might be right for
Retinal Vein OcclusionObstructive Sleep Apnea
Centre Hospitalier Régional d'Orléans
Post-approval studies (Phase 4)Study completedNCT01580020
What this trial is testing

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 175
Large-scale testing (Phase 3)Ended earlyNCT05127525
What this trial is testing

EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)

Who this might be right for
Diabetic Macular EdemaBranch Retinal Vein OcclusionGlaucoma/Closed Angle Glaucoma
iRenix Medical, Inc. 5
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Large-scale testing (Phase 3)Study completedNCT05520177
What this trial is testing

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 351
Not applicableStudy completedNCT06146309
What this trial is testing

Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Al-Azhar University 60
Not applicableStudy completedNCT01568021
What this trial is testing

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 100
Not applicableStudy completedNCT04137120
What this trial is testing

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Who this might be right for
Retinal Disease
Bayer 73
Not applicableUnknownNCT03637283
What this trial is testing

Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage

Who this might be right for
Anti-VEGFBranch Retinal Vein OcclusionVitrectomy
Wenzhou Medical University 100
Post-approval studies (Phase 4)Ended earlyNCT01795209
What this trial is testing

Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Seoul National University Bundang Hospital 19
Large-scale testing (Phase 3)Study completedNCT01599650
What this trial is testing

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 455
Early research (Phase 1)UnknownNCT01011374
What this trial is testing

Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion

Who this might be right for
Venous Retinal Branch OcclusionCentral Retinal Vein OcclusionRetinal Vein Occlusion+1 more
Retina Associates of Cleveland, Inc 45
Large-scale testing (Phase 3)Study completedNCT01512901
What this trial is testing

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

Who this might be right for
Macular Edema Following Branch Retinal Vein Occlusion
Santen Pharmaceutical Co., Ltd.
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Next Page